α1-3-galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-gal antobodies

Transplantation

Volumn 78, Issue 1, 2004, Pages 15-20

  Dor, Frank J M F ^a   Tseng, Yau Lin ^a   Cheng, Jane ^b   Moran, Kathleen ^b   Sanderson, Todd M ^b   Lancos, Courtney J ^a   Shimizu, Akira ^a,b   Yamada, Kazuhiko ^a   Awwad, Michel ^b   Sachs, David H ^a   Hawley, Robert J ^b   Schuurman, Henk Jan ^b   Cooper, David K C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Immerge Biotherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1,3 GALACTOSYLTRANSFERASE; ANTIBODY; DITHIOTHREITOL; EPITOPE; GALACTOSYLGALACTOSE; GALACTOSYLGALACTOSE ANTIBODY; GALACTOSYLTRANSFERASE; IB4 LECTIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; LECTIN; UNCLASSIFIED DRUG; DISACCHARIDE; GALACTOSYL (1 3)GALACTOSE; GALACTOSYL-(1-3)GALACTOSE; LYMPHOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL MEDIATED LYMPHOLYSIS; CELL NUCLEUS TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EMBRYO TRANSFER; FLOW CYTOMETRY; GRIFFONIA; GRIFFONIA SIMPLICIFOLIA; HAPLOTYPE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; KNOCKOUT GENE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECIPIENT; SWINE; WILD TYPE; XENOTRANSPLANTATION; ANIMAL; BLOOD; GENETICS; IMMUNOLOGY; MINIPIG; MONONUCLEAR CELL; MUTAGENESIS; XENOGRAFT;

ANIMALS; ANTILYMPHOCYTE SERUM; DISACCHARIDES; EPITOPES; GALACTOSYLTRANSFERASES; HAPLOTYPES; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; MUTAGENESIS; SWINE; SWINE, MINIATURE; TRANSPLANTATION, HETEROLOGOUS;

EID: 3142717365     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000130487.68051.EB     Document Type: Article

References (12)

1. Cooper DKC, Koren E, Oriol R. Genetically engineered pigs. Lancet 1993; 342: 682-683.
2. a. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 101: 7335.
3. Oriol R, Ye Y, Koren E, et al. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433-1442.
4. 4, isolated from Bandeiraea simplicifolia. Arch Biochem Biophys 1979; 198: 1-11.
5. Xu Y, Sablinski T, Gianello P, et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column. Transplantation 1998; 65: 172-179.
6. Pescovitz MD, Lunney JK, Sachs JH. Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells. J. Immunol 1985; 134: 37-44.
7. Kirkman RL, Colvin RB, Flye MW, et al. Transplantation in miniature swine, VII. Evidence for cellular immune mechanisms in hyperacute rejection of renal allografts. Transplantation 1979; 28: 24-30.
8. Kortz EO, Sakamoto K, Suzuki T, et al. Mechanism of tolerance following class I disparate renal allografts in miniature swine: cellular responses of tolerant animals. Transplantation 1990; 49: 1142-1149.
9. McKenzie IFC, Xing P-X, Vaughan HA, et al. Distribution of the major xenoantigen (gal(α1-3)gal) for pig to human xenografts. Transpl Immunol 1994; 2: 81-86.
10. Dor FJMF, Cheng J, Alt A, et al. Galα1,3Gal expression on porcine pancreatic islets, testis, spleen and thymus. Xenotransplantation 2004; 11: 101-106.
11. Galili U, Mandrell RE, Hamadeh RM, et al. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730-1737.
12. Thall AD, Murphy HS, Lowe JB. α1,3-galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant Proc 1996; 28: 556-557.